PCI in the ASC: Pursuing the shift of cardiovascular procedures to the outpatient setting
Tuesday, May 26th 2020 | 12:00 pm - 1:00 pm CST
With 2020 CMS approval of coronary interventions for reimbursement in the ASC space, now is the time to begin implementing and optimizing PCI procedures in your facility.
Join Jared Leger, RN, CEO and Co-Founder of Arise Vascular, and Dr. Comstock, Interventional Cardiologist and Founder of Tulsa Cardiovascular Center of Excellence, to learn about the business case for entering the PCI market, understanding the requirements for accreditation, the roadmap to getting started with PCI in a Ambulatory Surgery Center, and how to obtain essential buy-in from key players.
Jared and Dr. Comstock will share their initial experience related to this new market dynamic as well as observations of national and regional trends. All of these experiences can assist you as you look to enter and expand in the “PCI in the ASC” market.
In this webinar, speakers will discuss:
- Current landscape for coronary interventions in ASCs
- Evaluating and building a business case for establishing PCI in your ASC
- Best practices for implementing PCI procedures within your ASC
- Performance metrics and tools to monitor success
CEO and Co-Founder, Arise Vascular
Mr. Leger currently serves as the Co-Founder and CEO of Arise Vascular, which owns and operates free-standing outpatient cardiovascular centers in various markets. Previously, Mr. Leger co-founded Arise Healthcare, where he served as CEO and Managing Partner. At the helm, he led Arise Healthcare to be named one of Austin’s Top 50 Fastest Growing Companies and positioned the company and its subsidiaries for a strategic transaction with a publicly traded healthcare company in 2015. Mr. Leger’s background as a registered nurse coupled with his business acumen has allowed him to repeatedly start and grow healthcare businesses at an accelerated pace.
Matthew Comstock, D.O.
Interventional Cardiologist and Founder, Tulsa Cardiovascular Center of Excellence
Dr. Matthew J. Comstock is regarded as one of the nation’s leading interventional cardiologists. He specializes in cardiac rhythm management devices, advanced coronary interventions, hemodynamic support devices, venous interventions for DVT, PE and iliac vein compression, and complex peripheral vascular interventions with advanced atherectomy techniques, critical limb ischemia, and limb salvage training. Inspired by his passion for improving the health and quality of life in his patients, Dr. Comstock opened his practice to deliver custom personalized care. He established Tulsa Cardiovascular Center of Excellence in 2019, an outpatient revascularization lab, specializing in peripheral arterial disease, critical limb ischemia, limb salvage, enhanced wound healing, and amputation prevention.